Drug intelligence / Profile preview

magnesium beta-hydroxybutyrate

Development stage
Preclinical
Lead developer
Ketone Labs
Modality
Small Molecules
Administration
Oral
01

Overview

Magnesium beta-hydroxybutyrate is a *synthetic salt* combining the mineral magnesium with beta-hydroxybutyrate (BHB), a ketone body. BHB is produced endogenously during periods of low carbohydrate intake or fasting and acts as an alternative energy substrate, especially for the brain and muscle. Exogenously, magnesium beta-hydroxybutyrate may be used as a dietary supplement to *induce ketosis*, support energy metabolism, enhance cognitive and neurological function, and provide muscle and cardioprotective benefits. The compound's mechanism of action lies in BHB's ability to serve as an energy source, modulate inflammation by inhibiting the NLRP3 inflammasome, antagonize FFAR3, inhibit histone deacetylases (HDAC1, HDAC3, HDAC4) leading to changes in gene expression, and affect potassium channels and transporter modulation. Magnesium itself supports muscle and nerve function. Magnesium beta-hydroxybutyrate is primarily proposed as a dietary supplement rather than a pharmaceutical drug[1][2][3][4][6][8].

Brand names
magnesium beta-hydroxybutyrate
Other names
magnesium BHBmagnesium beta-OHBmagnesium β-hydroxybutyrate
02

Targets

KATP channel (ATP-sensitive potassium channel)HCAR2 (Hydroxycarboxylic acid receptor 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)HDAC (HDAC family)

Beyond the preview

Go deeper on magnesium beta-hydroxybutyrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on magnesium beta-hydroxybutyrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call